PharmaTelevision - BIA: Bringing success for its members

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BIA: Bringing success for its members

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

Dr Fintan Walton talks with Aisling Burnard, CEO of the BioIndustry Association (BIA) at the BIA Leadership Summit in Hertfordshire.

Aisling describes the purpose of the BIA and how it measures success. Topics covered include:

• What the BIA is about and how it differentiates itself from the regional associations through policy, public affairs, talking to the media and influencing government

• Measurement of success against its 3 year plan

• How it influences the European Union through lobbying and its involvement with EuropaBio

• The Association’s goals, (in relation to business issues, funding and helping members understand what is available to them, and the regulatory pathway) for the next 3-5 years

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

BioIndustry Association history and it's functions and measuring of successes.

Fintan Walton:

Hello and welcome to PharmaVentures business review here at the BIA Leadership Summit in Hertfordshire in the UK. On this show I have Aisling Burnand who is the Chief Executive of BIA, the BioIndustry Association here in the UK. Welcome to the show.

Aisling Burnand:

Thank you very much.

Fintan Walton:

Aisling Burnand, you play a critical role obviously in BIA. First of all just for our audience tell us what BIA is about and its function?

Aisling Burnand:

Well the BioIndustry Association is the national trade association for the bioscience sector in the United Kingdom and we represent our members interest to how venture stake holders and importantly government but also the media and we also provide a good forum for networking, exchanging best practice so that hopefully our members can thrive in and go forward and prosper.

Fintan Walton:

So how would you set your performance criteria for success? How would you measure your own successes in organization?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Aisling Burnard

Chief Executive Officer

Aisling Burnandhas been Chief Executive of the BioIndustry Association (BIA) since February 2003. Aisling Burnand joined the BIA in September 1998 as Director of Public Affairs, and has been responsible for all aspects of the Association's internal and external communications programmes. In 2001 she became Deputy Chief Executive. In June 2007 Aisling Burnand was awarded an MBE for her services to science. Prior to joining the BIA, Aisling Burnand was Business Group Director for the Rowland Company, a London based public affairs consultancy, where her clients included the European Commission as well as companies in the chemical, pharmaceutical, financial and consumer products sectors. Before that, she was head of international media relations for Rhone Poulenc in Paris and prior to that Public Relations Manager for Rhone Poulenc in the UK. Aisling Burnand sits on the Boards of EuropaBio, the UK Clinical Research Collaboration (UKCRC) and the Coalition for Medical Progress (CMP), and is a member of the London Stock Exchange Technology Advisory Group. Aisling Burnand is also a member of the Ministerial Industry Strategy Group, Long Term Leadership Strategy, Working Group on Partnership.

BioIndustry Association

The BioIndustry Association (BIA) is the trade association for innovative enterprises in the UK 's bioscience sector. Established in 1989, its mission is to �encourage and promote a thriving, financially sound sector of the UK economy, built upon developments across the biosciences.� The BIA seeks to create economic growth, increase employment opportunities and expand the skills base.